Global In-vitro Fertilization Services Market

Global In-vitro Fertilization Services Market by Products (In-vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI)), Cycle Type (Donor Egg IVF, Thawed IVF Cycles (Non-donor), and Cycles Fresh IVF Cycles (Non-donor)), Age Group (Below 34, 35-39, 40-42, 43 and above), End-users (Hospitals, Fertility Clinics, Clinical Research Institutes, Surgical Centers, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-3920
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 221
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global in-vitro fertilization services market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. In-vitro fertilization is the process in which ovum (egg) is removed from a female’s ovaries, and sperm from a male is allowed to fertilize egg in a liquid in laboratory.


Global In-vitro Fertilization Services Market summary

Market Trends, Drivers, Restraints, and Opportunities:

  • Increasing disposable income and high success rates of in-vitro fertilization services is fueling the market.
  • Rising infertility rate and delayed pregnancy is expected to drive the demand for in-vitro fertilization services in the coming years.
  • Increasing costs and complications in IVF treatment is expected to hamper the market growth.
  • Rising fertility tourism and fertility clinics is anticipated to provide lucrative opportunities for market players during the forecast period.

Scope of the report:

The report on in-vitro fertilization services market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

In-vitro fertilization services Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

By Product (In-vitro fertilization (IVF) and Intracytoplasmic sperm injection (ICSI)), Cycle Type (Donor Egg IVF, Thawed IVF Cycles (Non-donor), and Cycles Fresh IVF Cycles (Non-donor)), Age Group (Below 34, 35-39, 40-42, 43 and above), End-users (Hospitals, Fertility Clinics, Clinical Research Institutes, Surgical Centres, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Ambroise Paré Clinical Group, Bloom Fertility Centre, Bourn Hall, Chelsea and Westminster Hospital NHS Foundation Trust, Cyprus IVF Centre, Fertility Center Berlin, MANIPAL HEALTH ENTERPRISES PVT LTD, The Lister Hospital, Thomson Medical Pte Ltd, TRIO Fertility, Virtus Health, and Genea Perth Pty Ltd.

In-vitro fertilization services market Segment Insights:

The fresh IVF cycle segment is projected to hold significant market share

In terms of cycle types, the in-vitro fertilization services market can be segregated into donor egg IVF cycle, fresh IVF cycle, and thawed IVF cycle. The fresh IVF cycle segment held a considerable share of the market in 2020 owing to growing success rates of in-vitro fertilization. The thawed IVF cycle segment is estimated to expand at the significant CAGR during the forecast period owing to success rate in cases which are complicated such as in ovarian hyperstimulation syndrome.

The fertility clinics segment to grow during the forecast period

On the basis of end-users, the market can be segregated into fertility clinics, hospitals, surgical centers, clinical research institutes, and others. The fertility clinics segment is expected to hold a significant share of the market during the forecast period due to growing specialized healthcare professionals and rising number of fertility clinics.


Global In-vitro Fertilization Services Market end-users

The age group 35-39 segment to grow during the forecast period

Based on age groups, the market can be segregated into below 34, 35-39, 40-42, and 43 & above. The age group 35-39 segment is expected to hold a significant share of the market during the forecast period due to increasing pregnancy complexities.

The In-vitro fertilization (IVF) segment to grow during the forecast period

On the basis of products, the market can be bifurcated in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). The in-vitro fertilization (IVF) segment is anticipated to hold a significant share of the market during the forecast period due to increasing R&D and investment in this segment which ultimately propel the market.


Global In-vitro Fertilization Services Market products

Asia Pacific dominated the global market in 2020

In terms of regions, the global in-vitro fertilization services market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. Moreover, countries like China and India, which has high population are driving the market in Asia Pacific. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing awareness in the IVF treatment and increasing disposable income.


Global In-vitro Fertilization Services Market region

Segments

Segments Covered in the Report
Product

  • In-vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)

Cycle Type

  • Donor Egg IVF Cycles
  • Thawed IVF Cycles (Non-donor)
  • Fresh IVF Cycles (Non-donor)

Age Group

  • Below 34
  • 35-39
  • 40-42
  • 43 and Above

End-users

  • Hospitals
  • Fertility Clinics
  • Clinical Research Institutes
  • Surgical Centers
  • Others

Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key Players

  • Ambroise Paré Clinical Group
  • Bloom Fertility Centre
  • Bourn Hall
  • Chelsea and Westminster Hospital NHS Foundation Trust
  • Cyprus IVF Centre
  • Fertility Center Berlin
  • MANIPAL HEALTH ENTERPRISES PVT LTD
  • The Lister Hospital
  • Thomson Medical Pte Ltd
  • TRIO Fertility
  • Virtus Health
  • Genea Perth Pty Ltd.

 

Competitive Landscape

Key players in the in-vitro fertilization services market include Ambroise Paré Clinical Group, Bloom Fertility Centre, Bourn Hall, Chelsea and Westminster Hospital NHS Foundation Trust, Cyprus IVF Centre, Fertility Center Berlin, MANIPAL HEALTH ENTERPRISES PVT LTD, The Lister Hospital, Thomson Medical Pte Ltd, TRIO Fertility, Virtus Health, and Genea Perth Pty Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Global In-vitro Fertilization Services Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-vitro Fertilization Services Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In-vitro Fertilization Services Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In-vitro Fertilization Services Market - Supply Chain
  4.5. Global In-vitro Fertilization Services Market Forecast
     4.5.1. In-vitro Fertilization Services Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In-vitro Fertilization Services Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In-vitro Fertilization Services Market Absolute $ Opportunity
5. Global In-vitro Fertilization Services Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In-vitro Fertilization Services Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In-vitro Fertilization Services Demand Share Forecast, 2019-2026
6. North America In-vitro Fertilization Services Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In-vitro Fertilization Services Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In-vitro Fertilization Services Demand Share Forecast, 2019-2026
7. Latin America In-vitro Fertilization Services Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In-vitro Fertilization Services Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In-vitro Fertilization Services Demand Share Forecast, 2019-2026
8. Europe In-vitro Fertilization Services Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In-vitro Fertilization Services Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In-vitro Fertilization Services Demand Share Forecast, 2019-2026
9. Asia Pacific In-vitro Fertilization Services Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In-vitro Fertilization Services Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In-vitro Fertilization Services Demand Share Forecast, 2019-2026
10. Middle East & Africa In-vitro Fertilization Services Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In-vitro Fertilization Services Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In-vitro Fertilization Services Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In-vitro Fertilization Services Market: Market Share Analysis
  11.2. In-vitro Fertilization Services Distributors and Customers
  11.3. In-vitro Fertilization Services Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Ambroise Paré Clinical Group
     11.4.2. Bloom Fertility Centre
     11.4.3. Bourn Hall
     11.4.4. Chelsea and Westminster Hospital NHS Foundation Trust
     11.4.5. Cyprus IVF Centre
     11.4.6. Fertility Center Berlin
     11.4.7. MANIPAL HEALTH ENTERPRISES PVT LTD
     11.4.8.

Segments Covered in the Report
Product

  • In-vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)

Cycle Type

  • Donor Egg IVF Cycles
  • Thawed IVF Cycles (Non-donor)
  • Fresh IVF Cycles (Non-donor)

Age Group

  • Below 34
  • 35-39
  • 40-42
  • 43 and Above

End-users

  • Hospitals
  • Fertility Clinics
  • Clinical Research Institutes
  • Surgical Centers
  • Others

Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

Key Players

  • Ambroise Paré Clinical Group
  • Bloom Fertility Centre
  • Bourn Hall
  • Chelsea and Westminster Hospital NHS Foundation Trust
  • Cyprus IVF Centre
  • Fertility Center Berlin
  • MANIPAL HEALTH ENTERPRISES PVT LTD
  • The Lister Hospital
  • Thomson Medical Pte Ltd
  • TRIO Fertility
  • Virtus Health
  • Genea Perth Pty Ltd.

 

Key players in the in-vitro fertilization services market include Ambroise Paré Clinical Group, Bloom Fertility Centre, Bourn Hall, Chelsea and Westminster Hospital NHS Foundation Trust, Cyprus IVF Centre, Fertility Center Berlin, MANIPAL HEALTH ENTERPRISES PVT LTD, The Lister Hospital, Thomson Medical Pte Ltd, TRIO Fertility, Virtus Health, and Genea Perth Pty Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Global In-vitro Fertilization Services Market keyplayers

Buy Report